$GILD 4/A SEC Filings

Filed On	Filing
31 Mar 2021	Form 4/A: O'Day Daniel Patrick, Director Received 10,800 shares by exercise or conversion · Gave up 5,123 shares to cover exercise price or tax ($327K) · Granted 52,810 Restricted Stock Unit · 1 more
23 Aug 2017	Form 4/A: Kramer Kelly A., Director Received 1,339 shares by exercise or conversion
06 Apr 2011	Form 4/A: Young Kevin, EVP, Commercial Operations Received 23,250 shares as a grant or award · Gave up 9,924 shares to cover exercise price or tax ($395K)
06 Apr 2011	Form 4/A: Bischofberger Norbert W, EVP, R&D and CSO Received 20,250 shares as a grant or award · Gave up 9,452 shares to cover exercise price or tax ($376K)
05 Apr 2011	Form 4/A: Metza Kristen, SVP, Human Resources Received 9,194 shares as a grant or award · Gave up 3,372 shares to cover exercise price or tax ($134K)
05 Apr 2011	Form 4/A: Alton Gregg H, EVP, Corp & Med Affairs Received 10,020 shares as a grant or award · Gave up 4,676 shares to cover exercise price or tax ($186K)
05 Apr 2011	Form 4/A: Martin John C, Director Received 73,920 shares as a grant or award · Gave up 38,200 shares to cover exercise price or tax ($1.52M)
05 Apr 2011	Form 4/A: Milligan John F, President and COO Received 27,000 shares as a grant or award · Gave up 12,602 shares to cover exercise price or tax ($501K)
12 Nov 2010	Form 4/A: Berg Paul, Director Sold 12,000 shares ($471K)
12 Nov 2010	Form 4/A: Berg Paul, Director Sold 8,006 shares ($319K)
14 Jan 2009	Form 4/A: Berg Paul, Director Received 13,450 shares by exercise or conversion ($45.6K) · Sold 13,450 shares ($587K)
08 Jan 2009	Form 4/A: Moore Gordon Earle, Director Received 144,000 shares by exercise or conversion ($370K)
23 Dec 2008	Form 4/A: Milligan John F, President and COO Received 60,000 shares by exercise or conversion ($493K) · Sold 60,000 shares ($2.62M)
14 Oct 2008	Form 4/A: Young Kevin, EVP, Commercial Operations Sold 30,000 shares ($1.37M)
24 Jul 2008	Form 4/A: Denny James M, Director Exercised 24,800 Non-Qualified Stock Option (right to buy)
14 Jul 2008	Form 4/A: Metza Kristen, SVP, Human Resources Exercised 7,500 Non-qualified Stock Option
12 Feb 2008	Form 4/A: Bischofberger Norbert W, EVP, R&D and CSO Sold 20,000 shares ($927K) · Gave 5,550 shares as a gift
21 Jun 2007	Form 4/A: Hills Carla A, Director Granted 17.86 Phantom shares
02 Feb 2007	Form 4/A: Toole John J, SVP, Clinical Research Received 4,000 shares by exercise or conversion ($29.6K)
10 Aug 2005	Form 4/A: Cogan John Francis, Director Granted 1,223.02 Phantom Shares · Granted 6,000 Non-Qualified Stock Option (right to buy)

Comments